Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $3.36 +0.35 (+11.63%) Closing price 03/5/2025 04:00 PM EasternExtended Trading$3.36 0.00 (0.00%) As of 03/5/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Amylyx Pharmaceuticals Stock Price Performance 5 Day Performance+2.44%1 Month Performance-8.94%3 Month Performance-32.39%6 Month Performance+52.73%Year-To-Date Performance-11.11%1 Year Performance-82.18% Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address AMLX Stock Chart for Thursday, March, 6, 2025 AMLX Chart by TradingView Amylyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/05/2025$3.01$3.36+11.63%$3.40$3.00749,205 shs$230.32 million03/04/2025$3.00$3.01+0.33%$3.17$2.601.71 million shs$206.33 million03/03/2025$3.28$3.00-8.54%$3.32$2.991.30 million shs$205.64 million02/28/2025$3.16$3.28+3.80%$3.30$3.11277,919 shs$224.84 million02/27/2025$3.20$3.16-1.25%$3.22$3.10364,316 shs$216.61 million02/26/2025$3.06$3.20+4.58%$3.35$3.07684,184 shs$219.35 million02/25/2025$3.00$3.06+2.00%$3.14$2.87718,798 shs$209.76 million02/24/2025$3.30$3.00-9.09%$3.40$2.99936,675 shs$205.65 million02/21/2025$3.52$3.30-6.25%$3.58$3.28492,206 shs$226.22 million02/20/2025$3.52$3.52$3.65$3.44497,473 shs$241.30 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/19/2025$3.57$3.52-1.26%$3.63$3.42437,594 shs$241.30 million02/18/2025$3.72$3.57-4.17%$3.88$3.52666,978 shs$244.38 million02/17/2025$3.72$3.72$3.74$3.54374,325 shs$255.00 million02/14/2025$3.59$3.72+3.62%$3.74$3.54374,325 shs$255.01 million02/13/2025$3.53$3.59+1.70%$3.69$3.51330,924 shs$246.09 million02/12/2025$3.40$3.53+3.82%$3.59$3.30654,172 shs$241.98 million02/11/2025$3.74$3.40-9.09%$3.75$3.39656,552 shs$233.07 million02/10/2025$3.80$3.74-1.58%$3.95$3.64848,538 shs$256.38 million02/07/2025$3.75$3.80+1.33%$3.96$3.74658,189 shs$260.49 million02/06/2025$3.69$3.75+1.63%$3.83$3.67815,462 shs$257.06 million02/05/2025$3.62$3.69+1.93%$3.90$3.621.58 million shs$252.95 million02/04/2025$3.42$3.62+5.85%$3.71$3.361.00 million shs$248.15 million Related Companies Prothena Stock Chart Avid Bioservices Stock Chart Avadel Pharmaceuticals Stock Chart Bicycle Therapeutics Stock Chart Opthea Stock Chart Immunome Stock Chart Cronos Group Stock Chart CureVac Stock Chart Bicara Therapeutics Stock Chart Anavex Life Sciences Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 3/6/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
